Treatment News : ARVs Cause Massive Gains in Life Expectancy in South Africa

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » December 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


December 23, 2013

ARVs Cause Massive Gains in Life Expectancy in South Africa

Antiretrovirals (ARVs) added 9 to 11 years of life expectancy to HIV-positive South Africans who began treatment between 2004 and 2011, aidsmap reports. Publishing their findings in The Journal of Infectious Diseases, investigators analyzed data collected by the South African Catholic Bishops Conference and used the Cost-Effectiveness of Preventing AIDS Complications-International model of HIV disease and treatment (CEPAC) to project how rolling out ARVs affected the population.

South Africa has the largest number of people living with HIV of any country, at 5.6 million. About 2.8 million qualify for ARV treatment, although a third of them are not receiving therapy.

Just 50,000 people in the country started taking ARVs in 2004, a number that swelled to 557,000 in 2011. By the latter year, a total 2,222,700 had begun ARVs over the whole period of time. People with HIV could expect to live another two years on average if they were not on ARVs and 11 to 13 years if they were.

ARVs saved an estimated 21.7 million life years during this period.

To read the aidsmap story, click here.

To read the study abstract, click here.

To read a sample of the accompanying editorial, click here.

Search: Antiretrovirals, South Africa, AIDS, HIV, aidsmap, life expectancy, South African Catholic Bishops Conference, Cost-Effectiveness of Preventin AIDS Complications-International, CEPAC.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.